Document is current
Any future updates will be listed below
-
Authors
Dahmen, Victoria D. https://orcid.org/0009-0005-8105-6034
- License Information
-
More Information
Article History
Received: 28 July 2025
Revised: 14 August 2025
Accepted: 28 August 2025
First Online: 10 September 2025
Competing interests
: Professor Ian B Wilkinson has received research grants from AstraZeneca, GSK and scientific advisory board consultation fees for Viatris, Astra Zeneca and Roche. Professor Peter Sever has received consultation fees for scientific advisory boards and lectures from Viatris. Dr Luca Faconti, Dr Helen Warren, Dr Ryan McNally and Ms Victoria Dahmen have no competing interests to declare.
: Ethical approval was not required for this work as it did not involve any human or animal studies.
